NCT04347733View on ClinicalTrials.gov

Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for Shoulder

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

March 27, 2019

Study Completion Date

July 16, 2019

Conditions
Adhesive Capsulitis of Shoulder
Interventions
DRUG

Triamcinolone Acetonide 40mg/mL

We aimed to examine the therapeutic efficacy of the combination of hyaluronidase and steroid injection for adhesive capsulitis and to determine whether such a combination therapy might enable the total amount of steroids to be reduced.

DRUG

Hyaluronidase Injection

We aimed to examine the therapeutic efficacy of the combination of hyaluronidase and steroid injection for adhesive capsulitis and to determine whether such a combination therapy might enable the total amount of steroids to be reduced.

Trial Locations (1)

05368

Veterans Health Service Medical Center, Seoul

All Listed Sponsors
lead

Veterans Health Service Medical Center, Seoul, Korea

OTHER

NCT04347733 - Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for Shoulder | Biotech Hunter | Biotech Hunter